Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BTA | What did we get? | 14/08/21 | 77 | 41K | |||
|
|||||||
BTA | CORONAVIRUS being developed by VAXART | 13/08/21 | 18 | 46K | |||
|
|||||||
BTA | Vaxart - stop me | 13/11/20 | 3 | 3.0K | |||
|
|||||||
BTA | Covid and flu pill as well | 16:33 | 0 | 535 | |||
|
|||||||
BTA | h5n1-armageddon super virus recipe | 30/03/20 | 3 | 1.3K | |||
|
|||||||
BTA | Vaxart Merger | 15/03/18 | 27 | 21K | |||
|
|||||||
BTA | Voting Options | 02/02/18 | 6 | 4.2K | |||
|
|||||||
BTA | March quarter results | 01/07/17 | 8 | 5.9K | |||
|
See All Discussions